|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3149000 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15733532.4 |
| Date of filing the European patent application | 2015-05-26 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation | 2021-09-10 |
| (86) | Number | PCT/IB2015/053940 |
| Date | 2015-05-26 |
| (87) | Number | WO 2015/181728 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| 2596CH2014 | 2014-05-27 | IN | |
| 2597CH2014 | 2014-05-27 | IN |
| (72) |
VAKKALANKA, Swaroop Kumar Venkata Satya , CH
|
| (73) |
Rhizen Pharmaceuticals S.A. ,
Fritz Courvoisier 40, 2300 La Chaux de Fonds,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | PI3K delta selektyvaus inhibitoriaus kristalinės tozilato druskos panaudojimas farmacinėse kompozicijose |
| CRYSTALLINE TOSYLATE SALT OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-05-26 |